<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02721368</url>
  </required_header>
  <id_info>
    <org_study_id>MT_PRT_MVD01</org_study_id>
    <nct_id>NCT02721368</nct_id>
  </id_info>
  <brief_title>Neuramis® Volume Lidocaine Treatment in Patients With Loss of Mid-face Volume</brief_title>
  <official_title>Clinical Study of Neuramis® Volume Lidocaine to Evaluate the Efficacy and Safety for Temporary Restoring the Mid-face Volume</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medy-Tox</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medy-Tox</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Neuramis® Volume Lidocaine is effective in
      the temporary restoring the mid-face volume.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a multi-center, randomized, evaluator and subject blind, comparative medical
      device pivotal clinical trial.

      Efficacy and safety are evaluated at the appointed time that subject visit clinical site
      after injecting medical device.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2016</start_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement rate of the subject on the mid face volume deficit scale</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement rate of the subject on the global aesthetic improvement scale</measure>
    <time_frame>48 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>Neuramis® Volume Lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Neuramis® Volume Lidocaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Juvederm® Voluma® with Lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Juvederm® Voluma® with Lidocaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Neuramis® Volume Lidocaine</intervention_name>
    <description>hyaluronic acid filler</description>
    <arm_group_label>Neuramis® Volume Lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Juvederm® Voluma® with Lidocaine</intervention_name>
    <description>hyaluronic acid filler</description>
    <arm_group_label>Juvederm® Voluma® with Lidocaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female subject aged between 35 and 65.

          2. Subject who wanting to correct his/her mid-face volume deficit.

          3. Subject who agreed not to receive a cosmetic procedure or cosmetic surgery during the
             study period.

          4. Subjects who voluntarily decided the participation of the study and signed the
             informed consent.

        Exclusion Criteria:

          1. Subjects who had previous treatment at the mid-face for restoring volume.

          2. Subjects who had skin lesion caused by congenital defect, trauma and lipodystrophy
             etc.

          3. Subjects who had hypersensitivity to local anesthetic of amide type or lidocaine.

          4. Pregnant, lactating subjects or the childbearing subjects who disagreed with medically
             acceptable contraception.

          5. Subjects who have received any investigational product within 4 weeks prior to study
             participation and who are scheduled to take part in other clinical trial during the
             study period.

          6. Subjects who had medical history such as anaphylaxis or severe complex allergy.

          7. Subjects who had a mental disease which can be affect to this study or have severe
             disorder in the cardiovascular system, the digestive system, the respiratory system,
             the endocrine system and the central nervous system.

          8. Patients who are not eligible for this study at the medical discretion of the
             investigator.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>BeomJoon Kim</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chung-Ang Univ. Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chung-Ang Univ. Medical Center</name>
      <address>
        <city>Seoul</city>
        <state>Dongjak-gu</state>
        <zip>156-755</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2016</study_first_submitted>
  <study_first_submitted_qc>March 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2016</study_first_posted>
  <last_update_submitted>March 22, 2016</last_update_submitted>
  <last_update_submitted_qc>March 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

